These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 29394340)
1. Trends in optimal medical therapy prescription and mortality after admission for acute coronary syndrome: a 9-year experience in a real-world setting. Hoedemaker NPG; Damman P; Ottervanger JP; Dambrink JHE; Gosselink ATM; Kedhi E; Kolkman E; de Winter RJ; van 't Hof AWJ Eur Heart J Cardiovasc Pharmacother; 2018 Apr; 4(2):102-110. PubMed ID: 29394340 [TBL] [Abstract][Full Text] [Related]
2. Trends in optimal medical therapy at discharge and clinical outcomes in patients with acute coronary syndrome in Thailand. Wongsalap Y; Kengkla K; Poolpun D; Saokaew S J Cardiol; 2021 Jun; 77(6):669-676. PubMed ID: 33455848 [TBL] [Abstract][Full Text] [Related]
3. Optimal Medical Therapy Prescription in Patients with Acute Coronary Syndrome in the Netherlands: A Multicenter Pilot Registry. Hoedemaker NPG; de Winter RJ; Hof AV; Kolkman E; Damman P Am J Cardiovasc Drugs; 2021 Mar; 21(2):219-229. PubMed ID: 32783182 [TBL] [Abstract][Full Text] [Related]
4. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome. Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG; Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083 [TBL] [Abstract][Full Text] [Related]
5. Impact of Optimal Medical Therapy at Discharge on One-year Direct Medical Costs in Patients with Acute Coronary Syndromes: A Retrospective, Observational Database Analysis in China. He X; Wang Y; Cong H; Lu C; Wu J Clin Ther; 2019 Mar; 41(3):456-465.e2. PubMed ID: 30770126 [TBL] [Abstract][Full Text] [Related]
6. Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-Study. Iannaccone M; D Ascenzo F; De Filippo O; Gagliardi M; Southern DA; Raposeiras-Roubín S; Abu-Assi E; Henriques JPS; Saucedo J; González-Juanatey JR; Wilton SB; Kikkert WJ; Nuñez-Gil I; Ariza-Sole A; Song X; Alexopoulos D; Liebetrau C; Kawaji T; Huczek Z; Nie SP; Fujii T; Correia L; Kawashiri MA; García-Acuña JM; Alfonso E; Terol B; Garay A; Zhang D; Chen Y; Xanthopoulou I; Osman N; Möllmann H; Shiomi H; Kowara M; Filipiak K; Wang X; Yan Y; Fan JY; Ikari Y; Nakahashi T; Sakata K; Yamagishi M; Moretti C; Gaita F; Kalpak O; Kedev S Am J Cardiovasc Drugs; 2017 Feb; 17(1):61-71. PubMed ID: 27738920 [TBL] [Abstract][Full Text] [Related]
7. Optimal Medical Therapy on Top of Dual-Antiplatelet Therapy: 1-Year Clinical Outcome in Patients With Acute Coronary Syndrome: The START Antiplatelet Registry. Cirillo P; Di Serafino L; Taglialatela V; Calabrò P; Antonucci E; Gresele P; Palareti G; Patti G; Pengo V; Pignatelli P; Marcucci R Angiology; 2020 Mar; 71(3):235-241. PubMed ID: 31867981 [TBL] [Abstract][Full Text] [Related]
8. Determinants of Insufficient Optimal Medical Therapy after Acute Myocardial Infarction. Haraguchi Y; Sakakura K; Yamamoto K; Taniguchi Y; Tsukui T; Seguchi M; Wada H; Momomura SI; Fujita H Intern Med; 2020 Jun; 59(12):1489-1495. PubMed ID: 32188806 [TBL] [Abstract][Full Text] [Related]
9. Long-Term Quality of Prescription for ST-Segment Elevation Myocardial Infarction (STEMI) Patients: A Real World 1-Year Follow-Up Study. Bruggmann C; Iglesias JF; Gex-Fabry M; Fesselet R; Vogt P; Sadeghipour F; Voirol P Am J Cardiovasc Drugs; 2020 Feb; 20(1):105-115. PubMed ID: 31300969 [TBL] [Abstract][Full Text] [Related]
10. β-Blocker Therapy Prior to Admission for Acute Coronary Syndrome in Patients Without Heart Failure or Left Ventricular Dysfunction Improves In-Hospital and 12-Month Outcome: Results From the GULF-RACE 2 (Gulf Registry of Acute Coronary Events-2). Abi Khalil C; AlHabib KF; Singh R; Asaad N; Alfaleh H; Alsheikh-Ali AA; Sulaiman K; Alshamiri M; Alshaer F; AlMahmeed W; Al Suwaidi J J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29263035 [TBL] [Abstract][Full Text] [Related]
11. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value. Lee JH; Yang DH; Park HS; Cho Y; Jeong MH; Kim YJ; Kim KS; Hur SH; Seong IW; Hong TJ; Cho MC; Kim CJ; Jun JE; Park WH; Chae SC; Am Heart J; 2010 Jun; 159(6):1012-9. PubMed ID: 20569714 [TBL] [Abstract][Full Text] [Related]
13. Mortality benefit of long-term angiotensin-converting enzyme inhibitors or angiotensin receptor blockers after successful percutaneous coronary intervention in non-ST elevation acute myocardial infarction. González-Cambeiro MC; López-López A; Abu-Assi E; Raposeiras-Roubín S; Peña-Gil C; García-Acuña J; González-Juanatey R Rev Port Cardiol; 2016 Dec; 35(12):645-653. PubMed ID: 27865680 [TBL] [Abstract][Full Text] [Related]
14. Disparities in management patterns and outcomes of patients with non-ST-elevation acute coronary syndrome with and without a history of cerebrovascular disease. Lee TC; Goodman SG; Yan RT; Grondin FR; Welsh RC; Rose B; Gyenes G; Zimmerman RH; Brossoit R; Saposnik G; Graham JJ; Yan AT; Am J Cardiol; 2010 Apr; 105(8):1083-9. PubMed ID: 20381657 [TBL] [Abstract][Full Text] [Related]
15. A multicentre retrospective study to understand anti-platelet treatment patterns and outcomes of acute coronary syndrome patients in India (TRACE). Kaul U; Sethi KK; Dalal J; Parikh K; Hiremath MS; Mullasari AS; Nair T; Sandhu PS; Kotak B Indian Heart J; 2014; 66(3):334-9. PubMed ID: 24973840 [TBL] [Abstract][Full Text] [Related]
16. Predictors of 1-year outcomes in the Taiwan Acute Coronary Syndrome Full Spectrum Registry. Chiang FT; Shyu KG; Wu CJ; Mar GY; Hou CJ; Li AH; Wen MS; Lai WT; Lin SJ; Kuo CT; Kuo C; Li YH; Hwang JJ; J Formos Med Assoc; 2014 Nov; 113(11):794-802. PubMed ID: 24076272 [TBL] [Abstract][Full Text] [Related]
17. Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study. Pereira M; Araújo C; Dias P; Lunet N; Subirana I; Marrugat J; Capewell S; Bennett K; Azevedo A Eur J Prev Cardiol; 2014 Nov; 21(11):1401-8. PubMed ID: 23787795 [TBL] [Abstract][Full Text] [Related]
18. Use of evidence-based therapy for the secondary prevention of acute coronary syndromes in Malaysian practice. Kassab YW; Hassan Y; Aziz NA; Akram H; Ismail O J Eval Clin Pract; 2013 Aug; 19(4):658-63. PubMed ID: 22845427 [TBL] [Abstract][Full Text] [Related]
19. Effect of evidence-based cardiac drug therapy on mortality in patients with acute coronary syndrome: Findings from the Gulf COAST registry. Al-Zakwani I; Zubaid M; Alsheikh-Ali AA; Almahmeed W; Rashed W Cardiovasc Ther; 2018 Dec; 36(6):e12463. PubMed ID: 30079461 [TBL] [Abstract][Full Text] [Related]
20. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry). Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]